Carbapenemase-producing Pseudomonas aeruginosa in UK.
N
N
Woodford
M F
MF
Palepou
G S
GS
Babini
J
J
Bates
D M
DM
Livermore
D000583:Amikacin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology; D001426:Bacterial Proteins; D015780:Carbapenems / Q000494:pharmacology; D002442:Ceftazidime / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D000077731:Meropenem; D008667:Metalloproteins / Q000032:analysis / Q000378:metabolism*; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D010878:Piperacillin / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology* / Q000302:isolation & purification; D000078142:Tazobactam; D013845:Thienamycins / Q000494:pharmacology; D006113:United Kingdom; D018440:beta-Lactam Resistance; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000032:analysis / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D015780:Carbapenems; D004791:Enzyme Inhibitors; D005839:Gentamicins; D008667:Metalloproteins; D010406:Penicillins; D013845:Thienamycins; D065093:beta-Lactamase Inhibitors; D002939:Ciprofloxacin; D015378:Imipenem; D000583:Amikacin; D010397:Penicillanic Acid; D002442:Ceftazidime; D001618:beta-Lactamases; C063912:carbapenemase; D000077731:Meropenem; D000078142:Tazobactam; D010878:Piperacillin